Max Fehlmann Email & Phone Number

Brussels

Montreal, Quebec, Canada

I am in charge of a project to create an Innovation Zone in Montreal focused on Artificial Intelligence (AI) in health. This project, carried out jointly by Montreal InVivo and Montreal International, aims to mobilize all of the health AI players in Greater Montreal to accelerate the development and commercialization of innovations in AI applied to health and life sciences.

Founded in 1967, the Montreal Clinical Research Institute (IRCM) is a non-profit organization that conducts fundamental and clinical biomedical research in addition to training high-level young scientists in an innovative technological environment. The Institute brings together about 450 people as well as 35 laboratories, which work in cancer, immunology, neuroscience, cardiovascular and metabolic diseases, systems biology and medicinal chemistry. The IRCM also operates a research clinic specialized in hypertension, cholesterol and diabetes as well as a research centre on rare and genetic diseases in adults. The IRCM is affiliated with Université de Montréal and associated with McGill University. Its clinic is affiliated with the Centre hospitalier de l’Université de Montréal (CHUM). The IRCM is supported by the Ministère de l’Économie et de l’Innovation (Quebec Ministry of Economy and Innovation).https://ircm.qc.ca/

Montreal, Canada Area

Max has joined the Cancer Research Society as President and CEO in January 2017. Founded in 1945, the Cancer Research Society is the first Canadian foundation entirely dedicated to funding research on all types of cancer. Over the course of its history, the CRS has supported thousands of our country's best scientific minds who have helped make important strides in the way we prevent, detect, and treat cancer. Since 2000, thanks to the generosity of donors across the country, the CRS distributed over $140 million in research grants across Canada. Max is bringing to the CRS his experience in research, fundraising and management. He has been given the mandate to grow and position the CRS as a leader among fundraising organizations in Canada as well as increasing awareness about the potential of innovative partnerships by leading research into new cooperative practices. www.cancerresearchsociety.ca

Laval, Québec

NEOMED-LABS, a Canadian specialty company providing customized and high-throughput immune-monitoring for clinical vaccine and biologics development, is a spin-off from the GSK. Fully owned by the NEOMED Institute the facility is equipped with the latest platform technologies to conduct cutting-edge analyses of host responses to vaccines under GCLP conditions. Supported by an integrated system of laboratory robots and automated analyzers, the platforms allow high-throughput testing of clinical specimens to facilitate accelerated development of vaccines. LABS employs over 60 scientists and technicians. Max still has a seat on the Board of Directors of LABS. www.neomedlabs.com

Montreal, Canada Area

Max founded NEOMED in November 2012 as a not‐for‐profit organization whose mission is to bridge the gap between basic research and the commercialization of new drugs by providing industrial expertise in drug discovery and development, combined with the creation of a vibrant and sustainable life science ecosystem. NEOMED operates two fully integrated research and development campuses in Montreal: one specializing in small molecule therapeutics, and the other specializing in the development of biologics and vaccines. Both facilities function as open‐access drug discovery hubs housing independent commercial businesses (30 independent companies employing more than 300 people) and providing a dynamic environment that stimulates collaboration, innovation, and creativity. NEOMED is jointly funded by our pharmaceutical partners, the Ministère de l’Économie, de la Science et de l’Innovation du Québec, and the Networks of Centres of Excellence (NCE) of Canada. Max is still a sitting on the Board of Directors of NEOMED.www.neomed.ca

Montreal, Canada Area

Founded in 2008 CQDM is a not-for-profit pharma-based consortium active in biopharmaceutical research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM’s business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results. CQDM benefits from the financial support of 9 of the 12 largest pharmaceutical companies in the world, the Government of Quebec and the Government of Canada (Business Led-Networks of Centres of Excellence [BL-NCE] program). Since its inception, CQDM has raised $65 million, built an impressive portfolio of 60 outstanding technologies that impact biopharmaceutical research, and mobilized a national and international network of over 800 researchers from 74 different research institutions, universities, and small and medium-sized enterprises.www.cqdm.org

Montreal, Canada Area

Chronogen, Inc., a biotechnology company, researched and developed therapeutics to fight oxidative-stress disorders in age-related diseases. It provided inhibitors for neurodegenerative diseases and atherosclerosis, compounds with cellular oxidative stress modulator activities, compounds for the treatment of pulmonary, hepatic, and renal fibrosis and hypolipidemic compounds for anti-atherosclerotic effects. The company was founded in 1998 and was based in Montreal, Canada.

Milan Area, Italy

Vice-President R&D for Zambon Group in Italy responsible for all pre-clinical, clinical, and licensing activities of the group worldwide Founder of Z-cube, a corporate venture fund linked to Zambon Group.

Nice Area, France

La Gaude, France

A start-up company, spun-off from INSERM developing immuno- tools and services for the Pharmaceutical Industry. Aster was specialized in Reproductive Biology, Immunochemistry and Molecular Biology.

Nice Area, France

https://www.inserm.fr/

Nice Area, France

https://www.inserm.fr/

Nice Area, France

https://www.inserm.fr/

Nice Area, France

https://www.inserm.fr/

Greater Boston Area

Master Of Business Administration - Mba, Business Administration And Management, General

Activities and Societies: HEC-CPA

Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology

Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology